Healthcare Intelligence, Chapter Two: The United States of Healthcare

In the first issue of this series, we examined a simple but astonishing piece of arithmetic. Between 1990 and 2024, the United States spent dramatically more on healthcare while achieving only modest gains in life expectancy. Whether that arithmetic is viewed as a triumph of modern medicine or a warning about long-term sustainability, one conclusion is unavoidable: American healthcare has become one of the largest economic systems in human history. Its sheer scale demands a different way of thinking.

At approximately $5.3 trillion in annual expenditures, U.S. healthcare is no longer merely another sector of the economy. If American healthcare were measured as an independent national economy, it would exceed the annual economic output of Germany, Japan, the United Kingdom, France, and Canada. Entire nations operate with smaller economies than the amount Americans now spend on healthcare each year. Yet despite that extraordinary scale, healthcare is still discussed by many investors as though it were a single industry. It is not.

Healthcare Is Not a Single Industry

No prudent family office would analyze Europe as one investment opportunity. Germany is not France. Switzerland is not Italy. Each nation has its own economic strengths, industrial base, demographic profile, and public policy. Healthcare deserves the same discipline. Hospitals bear little resemblance to pharmaceutical manufacturers. Medicare Advantage plans operate under different economic realities than medical device companies. Healthcare technology companies compete under entirely different business models than home health providers. Behavioral health, diagnostics, physician practices, biotechnology, and consumer health each respond to different combinations of reimbursement, demographics, labor availability, innovation, regulation, and capital investment.

Where Stewardship Begins

That distinction is where stewardship begins. Most investment discussions begin with the question, “How much should we allocate to healthcare?” Family offices should ask a different question: “Where within healthcare should we allocate capital today?” Stewardship is not simply maintaining an allocation to healthcare. It requires understanding where each healthcare subsector resides within its own economic cycle. Healthcare spending may continue to expand while individual subsectors experience very different economic outcomes. Some will benefit from demographic tailwinds. Others will struggle under reimbursement pressure or regulatory change. Growing expenditures do not guarantee growing profitability.

The Medicare Actuaries have projected continued growth in national healthcare expenditures over the coming years. For long-term investors, the debate is no longer whether healthcare will continue growing. The more valuable question is where those additional dollars are likely to flow. That requires following the money.

From Arithmetic to Architecture

In the previous issue we established the arithmetic. In this issue we begin mapping the architecture. The national healthcare accounts reveal that healthcare is not a single destination for capital. Instead, the money disperses across hospitals, physician and clinical services, prescription drugs, home health, nursing care, dental care, public health activities, administrative costs, construction, and investment. Each category represents a distinct economic engine with different incentives, margins, regulatory exposure, and long-term prospects. Understanding those flows is essential for anyone attempting to allocate capital intelligently.

Healthcare is unique among major industries because its economic architecture cannot be understood without understanding Washington, D.C. policies. Few industries are influenced as continuously by federal policy. Congress appropriates. Presidential administrations establish priorities. The Centers for Medicare & Medicaid Services determine reimbursement methodologies. The Food and Drug Administration shapes the pace of innovation. The Department of Health and Human Services establishes regulatory frameworks that influence virtually every participant in the healthcare economy.

Since the administration of President Ronald Reagan, every President and every Congress has left a structural imprint on American healthcare. George H.W. Bush, Bill Clinton, George W. Bush, Barack Obama, Donald Trump, Joe Biden, and now President Trump once again have each inherited a healthcare system shaped by their predecessors while leaving new policies that will influence capital allocation for years after their administrations end. Regardless of politics, stewardship requires recognizing that healthcare evolves through the interaction of public policy and private enterprise.

The purpose of this series is not to recommend stocks or forecast quarterly earnings. It is to help family offices understand the architecture of one of the largest economies in the world. In the pages ahead, we will examine where healthcare dollars flow today and why some segments benefit more than others. In our next issue, we will turn the map around and ask an equally important question: we know where the money goes, but every dollar begins somewhere. Who ultimately pays for it?

About the Author

Noel J. Guillama is Healthcare Editor for Family Office Networks and Chairman of HealthScoreAI, Inc. He is a healthcare technology executive, entrepreneur, inventor, and investor with more than three decades of experience spanning healthcare delivery, health information technology, artificial intelligence, insurance, and capital markets. He holds 37 U.S. patents and writes on the intersection of healthcare, artificial intelligence, technology, and long-term investment trends.

Mr. Guillama also served for more than two decades in leadership roles with two public endowments, including Director, Treasurer, Chairman of the Investment Committee, Vice Chairman, and Chairman, helping oversee investment portfolios totaling more than $500 million in assets. This combination of healthcare operating experience, technology innovation, and long-term institutional investment stewardship informs his perspective on the intersection of healthcare, artificial intelligence, innovation, and capital allocation.